New Fragment-based Drug Discovery Platform Announced between IOTA and Beactica

News   Apr 24, 2008

 
New Fragment-based Drug Discovery Platform Announced between IOTA and Beactica
 
 
 

RELATED ARTICLES

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

Longevity Protein Could Help Treat Diabetes

News

beta-Klotho, a protein that regulates longevity, could have therapeutic potential for diabetes and obesity.

READ MORE

Arrow Poison Potential Male Birth Control

News

Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE